Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,801 | -19,512 | -10,012 | -35,087 | -25,508 |
| Depreciation Amortization | 1,085 | 548 | 266 | 322 | 65 |
| Other Working Capital | -1,589 | -1,820 | 272 | 881 | -224 |
| Other Operating Activity | 3,663 | 2,392 | 1,173 | 4,007 | 3,000 |
| Operating Cash Flow | $-27,642 | $-18,392 | $-8,301 | $-29,877 | $-22,667 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | -110 | -93 | -607 | -589 |
| Purchase Of Investment | -182,667 | -143,780 | -72,518 | -102,255 | -86,571 |
| Sale Of Investment | 108,961 | 67,284 | 33,281 | 123,281 | 105,901 |
| Investing Cash Flow | $-73,816 | $-76,606 | $-39,330 | $20,419 | $18,741 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 99,325 | 97,363 | 53,368 | 272 | 192 |
| Financing Cash Flow | $99,325 | $97,363 | $53,368 | $272 | $192 |
| Exchange Rate Effect | 15 | -20 | -117 | -45 | -83 |
| Beginning Cash Position | 14,951 | 14,951 | 14,951 | 24,182 | 24,182 |
| End Cash Position | 12,833 | 17,296 | 20,571 | 14,951 | 20,365 |
| Net Cash Flow | $-2,118 | $2,345 | $5,620 | $-9,231 | $-3,817 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,642 | -18,392 | -8,301 | -29,877 | -22,667 |
| Capital Expenditure | -110 | -110 | -93 | -607 | -589 |
| Free Cash Flow | -27,752 | -18,502 | -8,394 | -30,484 | -23,256 |